Thiodigalactoside (Synonyms: D-Galactopyranosyl-β-D-thiogalactopyranoside, Galactosyl 1-thiogalactoside, TDG) |
| Katalog-Nr.GC45040 |
Thiodigalactosid (TDG) ist ein oral aktiver und potenter Galectin (GAL)-Inhibitor mit Kd-Werten von 24 μM, 49 μM fÜr GAL1 bzw. GAL3.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 51555-87-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Galectins are a family of glycan-binding lectins with diverse regulatory roles in physiological processes. They have significant roles in inflammation and cancer. Thiodigalactoside is a diglycan that binds galectins-1, -3, -8, and -9 with Kd values between 24 and 78 µM. It is used to investigate the roles of these galectins in cell signaling and carcinogenesis.
Average Rating: 5 (Based on Reviews and 16 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *